Introduction
The association of diabetes with pregnancy still carries appreciable risk to the fetus and newborn. In recent years stricter control of the maternal plasma glucose has resulted in a decrease in perinatal mortality (Pedersen and Brandstrup, 1956; Oakley, 1965) but the approach is empirical because the cause of intrauterine death remains unknown. The newborn of the diabetic mother often develops profound hypoglycaemia (Farquhar, 1956 ) which may be due to hyperinsulinism (Cornblath, Joassin, Weisskopf, and Swiatek, 1966) ; thus it seems reasonable to postulate that the carbohydrate metabolism in utero of these babies is abnormal and may contribute in some measure to the increased risk of fetal death.
Earlier studies (Coltart, Beard, Turner, and Oakley, 1969; Beard, Turner, and Oakley, 1971) have shown that in the fasting state there is an increased maternal-fetal plasma glucose difference in diabetic compared with normal pregnancies. In addition when maternal hyperglycaemia of more than 200 mg/ 100 ml was induced in diabetic mothers by the administration of a 25-g intravenous glucose load the maternal-fetal difference in glucose concentration increased to between 55 and 100 mg/ 100 ml. It was not, however, clear from this study whether or not this wide maternal-fetal glucose difference was a feature peculiar to diabetic pregnancy, because persisting hyperglycaemia could not be produced by a single pulse of glucose in non-diabetic subjects. 
Patients and Methods
Glucose infusions were performed at the time of artificial rupture of the membranes, before the onset of labour, in two groups of patients*-firstly, a normal group of eight women without a history suggestive of diabetes and, secondly, a group of five gestational diabetics treated during pregnancy by diet alone. Four patients with severe insulin-treated diabetes who received single 25-g glucose loads also contributed glucose data to the diabetic group; the glucose assimilation of these patients was so impaired that a single pulse was enough to maintain a fairly uniform degree of hyperglycaemia for at least an hour. The patient groups were comparable with respect to body weight and no subject was grossly obese. The duration of gestation was not comparable, the normal pregnancies being induced at 40 to 42 weeks, usually for postmaturity, and the diabetics at 38 weeks, according to usual practice. All patients gave informed consent to the procedure. In previous studies (Beard et al., 1971 ) glucose pulses were given to 21 normal subjects and to 9 gestational diabetics, whose fasting glucose and insulin values were directly comparable to those of the present groups of patients. These data have been pooled with the infusion series to give a "cumulated patient series"; this larger group increases the information available for statistical analysis and provides a check on the consistency of the methodology.
Mothers undergoing surgical induction of labour, regardless of whether they were normal or diabetic, fasted for 12 hours before the study. The insulin-treated diabetics, all on controlled carbohydrate diets with twice-daily injections of soluble isophane insulin mixtures, were deprived of insulin on the morning of induction. After artificial rupture of the membranes and before the onset of labour capillary blood was collected from the fetus by means of the Saling technique (Saling, 1964) . This type of sampling has been in routine clinical use for the management of women with high-risk pregnancies during labour over the past six years. At the same time blood was taken from an antecubital vein of the mother. A priming dose of 25-75 ml of 50",, glucose was then given intravenously to the mother, followed by a continuous infusion of 50o,, glucose at the rate of 0-3-1-5 ml/ min, usually lasting 70 minutes. During this period the fetal heart rate and fetal blood pH were monitored. shown in Table III , in which the figures in parentheses refer to the "cumulated patient series." Mean plateau glucose values for the infusions are set out in Table IV . There was good agreement between the infusion series and the cumulated patient series with respect to all the values calculated; however, certain differences between normal and diabetic pregnancies reached statistical significance only in the larger group. The mean fasting maternal glucose concentration was higher in the gestational diabetics than in the normal patients (cumulated series, P <0 001). In contrast the glucose concentration in fetuses of gestational diabetics showed a tendency to be lower than that of the fetuses of normal mothers (0-05 <P <0-10); there is thus clear separation between the normal and gestational diabetic groups in terms of the mean maternal-fetal fasting plasma glucose difference of 6-5 mg/100 ml for the normal infusion series (8-0 mg/100 ml for the cumulated series) and 27-0 mg/100 ml for the gestational diabetic infusion series (31-6 mg/100 ml for the cumulated series). The four insulin-treated diabetic mothers had an even higher mean fasting plasma glucose level, and although the mean fetal value for this group was above that of the normal or gestational diabetic fetuses the mean maternal-fetal glucose difference of 37-5 mg/100 ml was higher than that of the normal or gestational diabetic patients.
The plateau plasma glucose values attained during glucose infusions or after glucose pulses showed definite trends. Varying rates of glucose infusion were used but despite maternal plateau values of up to over 300 mg/100 ml only one fetus (Case 6) reached a plateau glucose level of appreciably more than 200 mg/ 100 ml; this fetus developed asphyxia with accompanying tachycardia and acidosis shortly after the start of the infusion. It is possible that the high glucose concentration in this fetus may have been caused by increased mobilization or decreased tissue uptake of glucose in response to stress, and for this reason values from this patient have not been included in the determination of the mean plateau glucose values shown in Table IV . The mean maternal plateau values of 222 and 217 mg/ 100 ml in the normal and "combined diabetic" groups respectively are very close to one another. In contrast there is a small but significant difference (P <0-05) between the normal and combined diabetic fetal plateaux, the latter being lower.
INSULIN VALUES
Mean insulin values were calculated from log-transformed data, to conform to the accepted distribution of plasma insulin concentrations, fasting and after glucose ( (Table III) were similar in the gestational and diabetic mothers but the mean fasting fetal concentration for the gestational diabetic group was higher than normal (P <0 05 for the cumulated series) despite the lower glucose values of the fetuses of diabetic mothers.
Peak plasma insulin concentrations attained during glucose infusions are shown in Table I, with mean values in Table IV . The mean value for the gestational diabetic mothers was less than normal (P <0 001), confirming their diabetic status. Significant rises were observed in all fetuses studied (except in Case 5, where samples beyond 10 minutes could not be taken) although fetal and neonatal insulin responses to hyperglycaemia are known to be variable (Coltart et al., 1969; Gentz, Warrner, Persson, and Cornblath, 1969) ; the largest increases were seen in the gestational diabetics, and the mean peak insulin value for the diabetic group was slightly higher (P = 0 10) than that for the fetuses with normal mothers. Illustrative normal and gestational diabetic cases are shown in Figs. 1 and 2 . limit of maternal hyperglycaemia beyond which a further increase does not affect the fetal level. A possible explanation for this is that the facilitated diffusion system in the placenta (Widdas, 1961 ) is saturated by a high maternal glucose concentration.
In diabetic pregnancy the fasting fetal glucose values are lower and fasting maternal values higher than in normal pregnancy; a similar fetal trend is seen with sustained maternal hyperglycaemia. It seems likely that this can be ascribed to the associated fetal hyperinsulinism which was shown. Fasting hyperinsulinism was reported by Thomas, de Gasparo, and Hoet (1967) and by Obenshain et al. (1970) but this is the first report of an exaggerated fetal insulin response to glucose in diabetic pregnancy. The extent to which impaired placental glucose transport and increased placental glucose utilization contribute to the regulation of the fetal glucose level in diabetic pregnancies is not known.
The results of this study may provide a clue towards the cause of fetal death in diabetic pregnancies. The observation of hyperinsulinism in the fetuses of diabetic mothers, both fasting and after a glucose load, is likely to be the consequence of the islet hypertrophy found in these fetuses by Cardell (1953) . In conditions of maternal hyperglycaemia limited placental glucose transport and fetal hyperinsulinism combine to maintain the fetal plasma glucose concentration within the normal range. In fasting conditions, however, when the supply of glucose from the mother is greatly diminished hyperinsulinism apparently persists and could be responsible for severe fetal hypoglycaemia.
The adverse effects of hypoglycaemia on the fetus are not certain. On the one hand, maternal hypoglycaemia in late pregnancy is not regarded asa severe hazard to the fetus while, on the other hand, symptomatic neonatal hypoglycaemia may cause severe brain damage (Blattner, 1968; Haworth and McRae, 1965) . In normal women (Paterson, Page, Taft, Phillips, and Wood, 1968) and monkeys (Chez, Mintz, Horger, and Hutchinson, 1970 ) acute depression of maternal plasma glucose by exogenous insulin is associated with only mild depression of the fetal level, which sometimes becomes higher than that of the mother. This apparent resistance to maternal hypoglycaemia may depend on the ability of the normal fetus greatly to reduce its rate of glucose uptake or to mobilize its stores of glycogen. The actual fetal plasma glucose concentration is, however, only one factor, and tolerance of hypoglycaemia may also depend on the availability of alternative substrates such as free fatty acids and ketones for peripheral and cerebral metabolism; insulin may act by accelerating the net disposal of glucose, thus depressing the blood sugar, and also by lowering the plasma concentration of these alternative substrates. That insulin does more than just lower the plasma glucose is suggested by the observation that hypoglycaemia is accompanied by symptoms in the neonate only when the plasma insulin level is abnormally high (Cornblath, et al., 1966) .
Three clinical observations are consistent with the hypothesis that fetal hypoglycaemia induced by hyperinsulinism contributes to the perinatal mortality in diabetic pregnancy. Firstly, intrauterine death is most common near term, when the human fetal pancreas is fully mature and hyperinsulinism is likely to be maximal. Secondly, strict control of the blood sugar of the diabetic during the second half of pregnancy is known to lower perinatal mortality; it also ensures that the stimulus of hyperglycaemia to the fetal pancreatic islet is less, which probably leads to a reduction in hyperinsulinism and subsequent hypoglycaemia. Thirdly, increased fetal weight and fetal loss are known to characterize the prediabetic and early diabetic years as well as those when the disease is fully established-an observation that has always been difficult to explain; it may be that the pronounced fluctuations between hyperglycaemia and hypoglycaemia that occur in the early years of diabetes (Seltzer, Fajans, and Conn, 1956) (Kinsbourne, 1962) , "ocular oscillations and truncal myoclonus" (Baringer et al., 1968) , "dancing eyes, dancing feet, polymyoclonia" (Dyken and Kolar, 1968) to "infantile polymyoclonia-opsoclonus" (Moe and Nellhaus, 1970) . Moreover, some of these unusual motor phenomena have been described in young children with neuroblastoma as "oculo-cerebello-myoclonic syndrome" (Lemerle et al., 1969 
